The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/apt.13717PMID 27385373
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

  2015cited by this paper
• Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease

  2015cited by this paper
• Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.

  2015cited by this paper
• Actin Cytoskeletal Disruption following Cryopreservation Alters the Biodistribution of Human Mesenchymal Stromal Cells In Vivo

  2014cited by this paper
• A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.

  2014cited by this paper
• IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells

  2014cited by this paper
• Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

  2013cited by this paper
• The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

  2013cited by this paper
• Treatment with mesenchymal stromal cells is a risk factor for pneumonia‐related death after allogeneic hematopoietic stem cell transplantation

  2012cited by this paper
• Multipotent mesenchymal stromal cells and the innate immune system

  2012cited by this paper
• The immune plasticity of mesenchymal stromal cells from mice and men: concordances and discrepancies.

  2012cited by this paper
• New insights on translational development of mesenchymal stromal cells for suppressor therapy

  2012cited by this paper
• Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

  2011cited by this paper
• Immunogenicity of anti-TNF antibodies. Has the veil been lifted?

  2011cited by this paper
• Good Manufacturing Practices Production of Mesenchymal Stem/Stromal Cells

  2011cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

  2011cited by this paper
• Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.

  2011cited by this paper
• Use of immunomodulators and biologic therapies in children with inflammatory bowel disease

  2010cited by this paper
• Immunogenicity of anti-TNF antibodies. Has the veil been lifted?

  2010cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

  2010cited by this paper
• Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy.

  2009cited by this paper
• Hepatosplenic T‐cell lymphoma in adolescents and young adults with Crohn's disease: A cautionary tale?

  2007cited by this paper
• Although Pig Allogeneic Mesenchymal Stem Cells Are Not Immunogenic In Vitro, Intracardiac Injection Elicits an Immune Response In Vivo

  2007cited by this paper
• Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.

  2007cited by this paper
• Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density1

  2007cited by this paper
• Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities

  2006cited by this paper
• Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice.

  2005cited by this paper
• Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy.

  2004cited by this paper
• Etiopathogenesis of Inflammatory Bowel Disease: The Importance of the Pediatric Perspective

  2002cited by this paper

• Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions

  2026cites this paper
• Human platelet lysate produced from leukoreduction filter contents enables sufficient MSC growth

  2025cites this paper
• The Immunomodulatory mechanism and research progress of mesenchymal stem cells in the treatment of allergic rhinitis

  2025cites this paper
• Safety of intravenous mesenchymal stem cell therapy: a meta-analysis of randomized controlled trials

  2025cites this paper
• Exploring the Potential of Stem Cells in Modulating Gut Microbiota and Managing Hypertension

  2025cites this paper
• Human placenta mesenchymal stromal cells alleviate intestinal inflammation and repair intestinal barrier function by activating AMPK-FXR pathway

  2025cites this paper
• Targeted delivery of Grem1 and IL-10 separately by mesenchymal stem cells effectively mitigates SETD2-deficient inflammatory bowel disease

  2025cites this paper
• Bone marrow mesenchymal stromal cells support regeneration of intestinal damage in a colitis mouse model, independent of their CXCR4 expression

  2024cites this paper
• Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review.

  2024cites this paper
• A Comprehensive Exploration of Therapeutic Strategies in Inflammatory Bowel Diseases: Insights from Human and Animal Studies

  2024cites this paper
• Engineered Mesenchymal Stem Cells as Treatment for Cancers: Opportunities, Clinical Applications and Challenges

  2024cites this paper
• Refractory Crohn’s Disease: Perspectives, Unmet Needs and Innovations

  2024cites this paper
• Small extracellular vesicles derived from adipose mesenchymal stem cells alleviate intestinal fibrosis by inhibiting the FAK/Akt signaling pathway via MFGE8

  2024cites this paper
• Optimization of transplantation methods using isolated mesenchymal stem/stromal cells: clinical trials of inflammatory bowel diseases as an example

  2024cites this paper
• Vascular Endothelial Growth Factor secretion and immunosuppression are distinct potency mechanisms of Human Bone Marrow Mesenchymal Stromal Cells.

  2024cites this paper
• Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease

  2024influential citation
• Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy

  2023cites this paper
• Advance in oral delivery of living material

  2023cites this paper
• Mechanism, current status, and prospects of MSC and its extracellular vesicles in the treatment of IBD

  2023cites this paper
• Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?

  2023cites this paper
• Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches

  2023cites this paper
• The Impact of Cellular Therapies on Gastrointestinal Diseases: Applications and Challenges

  2023cites this paper
• Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges

  2023cites this paper
• Study Advances in the Treatment of Perianal Fistulizing Crohn’s Disease with Mesenchymal Stem Cells

  2023cites this paper
• Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3 + Treg cells and gut microbiota

  2023cites this paper
• Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

  2023cites this paper
• Mesenchymal Stem/Stromal Cells and Hydrogel Scaffolds for Tissue Engineering

  2022cites this paper
• Stem cell therapy: light in the tunnel for penetrating Crohn's disease

  2022cites this paper
• Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease

  2022cites this paper
• Review of the Published Literature Confirms the Safety of Intravenous Infusion of Mesenchymal Stem Cells.

  2022cites this paper
• Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges

  2022cites this paper
• Bioinspired All-in-One Three-Dimensional Dynamic CellMatrix Improves the Manufacture of Therapeutically Qualified Cells for Cell Therapy.

  2022cites this paper
• From Vial to Vein: Crucial Gaps in Mesenchymal Stromal Cell Clinical Trial Reporting

  2022cites this paper
• The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer

  2022cites this paper
• Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells.

  2022cites this paper
• Intraperitoneally Delivered Mesenchymal Stem Cells Alleviate Experimental Colitis Through THBS1-Mediated Induction of IL-10-Competent Regulatory B Cells

  2022cites this paper
• Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases

  2022cites this paper
• Single-Cell Transcriptome Integration Analysis Reveals the Correlation Between Mesenchymal Stromal Cells and Fibroblasts

  2022cites this paper
• Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases

  2022cites this paper
• Biological Aspects of Cell Culture Security In Vitro

  2021cites this paper
• Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review

  2021cites this paper
• Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges

  2021cites this paper
• Mesenchymal Stromal Cells Rapidly Suppress TCR Signaling-Mediated Cytokine Transcription in Activated T Cells Through the ICAM-1/CD43 Interaction

  2021cites this paper
• Strategies to Potentiate Paracrine Therapeutic Efficacy of Mesenchymal Stem Cells in Inflammatory Diseases

  2021cites this paper
• Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results

  2021cites this paper
• Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials.

  2021cites this paper
• ECCO topical review: Refractory IBD.

  2021cites this paper
• Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells

  2021cites this paper
• Stem cell therapy for Crohn’s disease: systematic review and meta-analysis of preclinical and clinical studies

  2021cites this paper
• mRNA-engineered mesenchymal stromal cells expressing CXCR2 enhances cell migration and improves recovery in IBD

  2021cites this paper
• Use of Mesenchymal Stem Cells in Crohn's Disease and Perianal Fistulas: A Narrative Review.

  2021cites this paper
• Role of mesenchymal and other stem cell therapy in intestinal diseases

  2021cites this paper
• Improving the Efficacy of Mesenchymal Stem/Stromal-Based Therapy for Treatment of Inflammatory Bowel Diseases

  2021cites this paper
• Biological aspects of security cell culture in vitro

  2021cites this paper
• An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells

  2020influential citation
• Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).

  2020cites this paper
• Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy

  2020cites this paper
• Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease

  2020cites this paper
• Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization

  2020cites this paper
• Emerging treatments for inflammatory bowel disease

  2020cites this paper
• CELL THERAPY IN INFLAMMATORY BOWEL DISEASE.

  2020cites this paper
• Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial

  2020cites this paper
• The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer

  2020cites this paper
• The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity

  2019cites this paper
• Perspectives of the International Society of Cell & Gene Therapy Gastrointestinal Scientific Committee on the Intravenous Use of Mesenchymal Stromal Cells in Inflammatory Bowel Disease (PeMeGi).

  2019cites this paper
• A highly standardized and characterized human platelet lysate for efficient and reproducible expansion of human bone marrow mesenchymal stromal cells.

  2019cites this paper
• Preparation of polycarbonate/gelatine microspheres using a high-voltage electrostatic technique for enhancing the adhesion and proliferation of mesenchymal stem cells

  2019cites this paper
• Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions

  2019cites this paper
• Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.

  2019cites this paper
• The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.

  2019cites this paper
• Mesenchymal stem cell–gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect

  2019cites this paper
• Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases

  2019cites this paper
• Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity

  2019cites this paper
• Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases

  2019cites this paper
• Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease

  2019cites this paper
• Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System

  2019cites this paper
• Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn’s disease – review of pathomechanism and existing clinical data

  2018cites this paper
• Immunotherapy in inflammatory bowel disease: Novel and emerging treatments

  2018cites this paper
• Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.

  2018cites this paper
• Mammalian MSC from selected species: Features and applications

  2018cites this paper
• Systematic Exposition of Mesenchymal Stem Cell for Inflammatory Bowel Disease and Its Associated Colorectal Cancer

  2018cites this paper
• Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature

  2018influential citation
• Mesenchymal stromal cell therapy in intestinal diseases

  2018cites this paper
• Mesenchymal stromal cells: an opportunity to treat chronic inflammatory intestinal conditions.

  2018cites this paper
• Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II study.

  2018cites this paper
• Ethical and Safety Issues of Stem Cell-Based Therapy

  2018influential citation
• Advances in mesenchymal stromal cell therapy in the management of Crohn’s disease

  2018cites this paper
• Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course.

  2017cites this paper
• Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?

  2017cites this paper
• Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Past, Present, and Future

  2017cites this paper
• Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases

  2017cites this paper
• Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn’s disease

  2017cites this paper
• From "Bench to Bedside": Current Advancement on Large-Scale Production of Mesenchymal Stem Cells.

  2017cites this paper
• Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.

  2017cites this paper
• Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer

  2017cites this paper
• Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases

  2017cites this paper
• Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.

  2017cites this paper
• Mesenchymal stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission

  2017cites this paper
• Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease via CD39–CD73–Adenosine and IDO Signals

  2017cites this paper
• Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease

  2017cites this paper